TEL AVIV The TA-25 Index climbed for a second time this week, increasing 14.33, or 1.5 percent, to 948.46 at the close in Tel Aviv. The benchmark measure dropped 1% this week. Investors traded about NIS 1.56 billion in shares and convertible securities. Clal Biotechnology Industries advanced 2.3%. The company, which invests in biotechnology firms, said its MediWound unit has completed recruitment for a Phase III clinical trial of its Debrase drug. Delta-Galil Industries increased 4.2%. The maker of woman's intimate apparel reported second-quarter net income of $ 211,000 after a loss of $684,000 a year earlier. First International Bank of Israel rose 4.4%. The country's fifth-largest lender said it would increase its holding in Bank Poaley Agudat Israel to 100% from 68.7%. WALL STREET US stocks rose for a third day as American International Group said it expects to repay the government, and data on manufacturing and economic indicators added to evidence the recession may be ending. The S&P 500 rose 0.9% to 1,005.16 at 2:02 p.m. in New York. The Dow Jones Industrial Average jumped 52.67 points, or 0.6%, to 9,331.83. EUROPE European stocks climbed the most in two weeks as companies reported earnings that topped analysts' estimates, while higher copper prices lifted raw-material producers. National benchmark indexes gained in all 18 western European markets except Luxembourg. The UK's FTSE 100 advanced 1.4% to 4,756.58. Germany's DAX added 1.5%, and France's CAC 40 rose 1.6%. ASIA Asian stocks advanced. Japan's Nikkei 225 Stock Average advanced 1.8% to 10,383.41. Hong Kong's Hang Seng Index climbed 1.9%. China's Shanghai Composite Index rose 4.5%, following Wednesday's 4.3% drop.